Showing posts with label Oligonucleotides. Show all posts
Showing posts with label Oligonucleotides. Show all posts
Friday, October 21, 2011

New data on novel gene-silencing oligonucleotide technology...

›
Idera announced new data on its novel gene-silencing oligonucleotide (GSO) technology at the Cell Symposium on Regulatory RNAs in Chicag...
Wednesday, March 10, 2010

Japanese patent for Archexin (a novel anti-cancer drug)....

›
Rexahn Pharmaceuticals, Inc. , a clinical stage pharmaceutical company commercializing potential best in class oncology and...
2 comments:
Tuesday, January 26, 2010

SPC3649 ( LNA- locked nucleic acid) - a new hope for hepatitis C.....

›
When  I was working with Innovasynth Technologies , Khopoli , I had an opportunity to do literature survey about  Lock Nucleic Acids (LN...
Saturday, December 5, 2009

First live targeting of tumors with RNA-based technology

›
Researchers at Duke University Medical Center have devised a way they might deliver the right therapy directly to tumors using special molec...
Friday, November 20, 2009

Positive results from mipomersen- a new hope for FH sufferers...

›
About Familial hypercholesterolemia : Familial hypercholesterolemia (also spelled familial hypercholesterolaemia ) is a genetic disorder ch...
Sunday, November 8, 2009

Antisense Therapeutics completes repeat-dosing toxicology studies for ATL1103

›
Antisense Therapeutics completes repeat-dosing toxicology studies for ATL1103 One can see the products under development...( by the same co ...
Saturday, October 24, 2009

Phase III clinical study of trabedersen....

›
In my earlier blogs , did mention about the " antisense drugs belonging to (Geron corporation) phosphorothioate antisense oligonucleoti...